"Ebolavirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus in the family FILOVIRIDAE consisting of several distinct species of Ebolavirus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease (HEMORRHAGIC FEVER, EBOLA) in humans, usually with high mortality.
| Descriptor ID |
D029043
|
| MeSH Number(s) |
B04.820.455.300.200
|
| Concept/Terms |
Ebolavirus- Ebolavirus
- Ebolaviruses
- Ebola Virus
- Ebola Viruses
- Virus, Ebola
- Viruses, Ebola
- Ebola-like Viruses
- Ebola like Viruses
- Ebola-like Virus
|
Below are MeSH descriptors whose meaning is more general than "Ebolavirus".
Below are MeSH descriptors whose meaning is more specific than "Ebolavirus".
This graph shows the total number of publications written about "Ebolavirus" by people in this website by year, and whether "Ebolavirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2015 | 3 | 1 | 4 |
| 2016 | 6 | 1 | 7 |
| 2017 | 5 | 2 | 7 |
| 2018 | 11 | 2 | 13 |
| 2019 | 3 | 0 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 8 | 0 | 8 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ebolavirus" by people in Profiles.
-
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system Commun Biol. 2024 07 17; 7(1):871.
-
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin. Cell Rep. 2023 10 31; 42(10):113254.
-
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Rep. 2023 04 25; 42(4):112370.
-
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathog. 2022 05; 18(5):e1010518.
-
Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development. Front Immunol. 2021; 12:808047.
-
Transcriptomic signatures induced by the Ebola virus vaccine rVSV?G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study. Lancet Microbe. 2022 02; 3(2):e113-e123.
-
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. Emerg Microbes Infect. 2021 Dec; 10(1):651-663.
-
Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 2021 10 28; 184(22):5593-5607.e18.
-
A computational overview on phylogenetic characterization, pathogenic mutations, and drug targets for Ebola virus disease. Curr Opin Pharmacol. 2021 12; 61:28-35.
-
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Front Immunol. 2021; 12:706757.